`
`‘Last hope‘ drug for prostate cancer patients is axed from the NHS,
`
`in a move doctors call a ‘travesty‘
`
`Jetvana gives men with prostate cancer at least three months of life
`
`But some men given the drug have survived three or more years
`
`Cancer Drugs Fund plans to axe drug from its approved list from March
`
`They say it is not cost-effective and doesn't offer ‘sufficient clinical benefit‘
`
`Charities say the appraisal system for drugs is broken, failing patients
`
`40,000 men in Britain diagnosed each year, over 10,000 die from disease
`
`Published: 08:04 EST, 9 January 2015 | Updated: 16:45 EST, 9 January 2015
`
`132
`
`I
`
`'7'”- n.'.: or-:!an.i't;or'l:il's
`
`Share this article
`
`Share
`
`132 shares
`
`The decision to stop NHS use of Jevtana — it has already been rejected by the rationing body NICE — follows
`
`news that six breast cancer drugs prescribed for thousands of women are also set to be axed.Some men
`
`whose prostate cancer has spread will have no other treatment option.Dr Alison Birtle, consultant clinical
`
`oncologist at Lancashire Teaching Hospitals NHS Foundation Trust, said the decision was a travesty.She
`
`AVENTIS EXHIBIT 2064
`Mylan v. Aventis, IPR2016-00712